Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
18
08
2022
accepted:
21
02
2023
medline:
12
6
2023
pubmed:
7
4
2023
entrez:
6
4
2023
Statut:
epublish
Résumé
Pulmonary arterial hypertension (PAH) is characterised by loss of microvessels. The Wnt pathways control pulmonary angiogenesis but their role in PAH is incompletely understood. We hypothesised that Wnt activation in pulmonary microvascular endothelial cells (PMVECs) is required for pulmonary angiogenesis, and its loss contributes to PAH. Lung tissue and PMVECs from healthy and PAH patients were screened for Wnt production. Global and endothelial-specific Healthy PMVECs demonstrated >6-fold Wnt7a expression during angiogenesis that was absent in PAH PMVECs and lungs. Wnt7a expression correlated with the formation of tip cells, a migratory endothelial phenotype critical for angiogenesis. PAH PMVECs demonstrated reduced vascular endothelial growth factor (VEGF)-induced tip cell formation as evidenced by reduced filopodia formation and motility, which was partially rescued by recombinant Wnt7a. We discovered that Wnt7a promotes VEGF signalling by facilitating Y1175 tyrosine phosphorylation in vascular endothelial growth factor receptor 2 (VEGFR2) through receptor tyrosine kinase-like orphan receptor 2 (ROR2), a Wnt-specific receptor. We found that ROR2 knockdown mimics Wnt7a insufficiency and prevents recovery of tip cell formation with Wnt7a stimulation. While there was no difference between wild-type and endothelial-specific Wnt7a promotes VEGF signalling in lung PMVECs and its loss is associated with an insufficient VEGF-A angiogenic response. We propose that Wnt7a deficiency contributes to progressive small vessel loss in PAH.
Identifiants
pubmed: 37024132
pii: 13993003.01625-2022
doi: 10.1183/13993003.01625-2022
pmc: PMC10259331
pii:
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL159443
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL164791
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139664
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL150106
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134776
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright ©The authors 2023.
Déclaration de conflit d'intérêts
Conflict of interest: V.A. de Jesus Perez reports support for the present manuscript from the National Institutes of Health National Heart, Lung, and Blood Institute; and outside the submitted work, holds a leadership position as AHA Chair of Diversity subcommittee. All other authors have nothing to disclose.
Références
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1656-64
pubmed: 19433307
Blood. 2010 Nov 11;116(19):4025-33
pubmed: 20705756
Angiogenesis. 2012 Mar;15(1):151-63
pubmed: 22249946
Elife. 2020 Jun 02;9:
pubmed: 32484158
Sci Rep. 2015 Nov 05;5:16151
pubmed: 26537366
JCI Insight. 2021 Mar 8;6(5):
pubmed: 33497360
Am J Med Genet A. 2012 Oct;158A(10):2463-72
pubmed: 22965740
ScientificWorldJournal. 2002 Feb 15;2:434-54
pubmed: 12806028
Cell Physiol Biochem. 2017;44(3):1251-1262
pubmed: 29179185
J Cell Commun Signal. 2016 Dec;10(4):347-354
pubmed: 27619687
Am J Respir Crit Care Med. 2022 Jan 15;205(2):208-218
pubmed: 34752721
Am J Respir Cell Mol Biol. 2019 May;60(5):503-514
pubmed: 30620615
Dev Dyn. 2006 Nov;235(11):3110-20
pubmed: 17013885
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33497359
Circulation. 2019 Apr 2;139(14):1710-1724
pubmed: 30586764
PLoS Comput Biol. 2015 Jun 12;11(6):e1004158
pubmed: 26067165
Dev Cell. 2011 Feb 15;20(2):163-76
pubmed: 21316585
Hypertension. 2021 Dec;78(6):1914-1926
pubmed: 34689593
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
pubmed: 16633338
Am J Respir Cell Mol Biol. 2014 Oct;51(4):474-84
pubmed: 24932885
Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L600-7
pubmed: 10956636
Am J Respir Crit Care Med. 2014 May 15;189(10):1260-72
pubmed: 24702692
Cell Adh Migr. 2011 Sep-Oct;5(5):402-8
pubmed: 21975549
Eur Respir J. 2020 Apr 3;55(4):
pubmed: 31980491
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177
pubmed: 26837729
Dev Dyn. 2010 Jan;239(1):1-15
pubmed: 19530173
Pulm Circ. 2020 Feb 28;10(1):
pubmed: 32166015
J Angiogenes Res. 2010 Jan 14;2:1
pubmed: 20150991
Circ Res. 2012 Dec 7;111(12):1551-64
pubmed: 23011394
Nat Commun. 2021 Mar 10;12(1):1565
pubmed: 33692365
J Cell Biol. 2009 Jan 12;184(1):83-99
pubmed: 19139264
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78
pubmed: 17522591
J Biol Chem. 2005 May 20;280(20):19625-34
pubmed: 15705594
Methods Mol Biol. 2019;1956:363-370
pubmed: 30779045